Britt I Drögemöller

Dec 4, 2023 | ascpt.onlinelibrary.wiley.com | David Twesigomwe |Britt I Drögemöller |Rady Faculty |Max Rady College

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? ☑ CYP2B6 and CYP2A6 genetic variation contributes to clinically relevant differences in response to antiretrovirals, nicotine, and bupropion (among other drugs) across individuals and populations. CYP2B6 and CYP2A6 are therefore important genes in clinical pharmacogenetic implementation initiatives globally.